Table 2.
Age, blood test results, and androgen levels at study baseline before enzalutamide treatment
| Variable | Median | Mean | SD |
|---|---|---|---|
| Age (yr) | 73.0 | 72.6 | 8.18 |
| Prostate-specific antigen (ng/ml) | 23.1 | 69.3 | 126.8 |
| Hemoglobin (g/dl) | 12.3 | 12.0 | 1.78 |
| Alkaline phosphatase (IU/l) | 267.0 | 344.4 | 257.9 |
| Lactate dehydrogenase (IU/l) | 222.0 | 254.8 | 153.9 |
| Calcium (mg/dl) | 9.4 | 9.3 | 0.55 |
| Albumin (g/dl) | 3.9 | 3.9 | 0.49 |
| Testosterone (pg/ml) | 49.0 | 59.7 | 67.0 |
| Dihydrotestosterone (pg/ml) | 5.80 | 8.37 | 7.80 |
| Androstendione (pg/ml) | 326.3 | 482.6 | 501.1 |
| Dehydroepiandrostendione sulfate (pg/ml) | 222.2 | 236.4 | 201.9 |
SD = standard deviation.